Epigenetic silencing of Ras-association domain family 1A (RASSF1A) protein in cancer cells results in a disruption of cell cycle control, genetic instability, enhanced cell motility, and apoptotic resistance. Ectopic expression of RASSF1A reverses this tumorigenic phenotype. Thus, small molecules with the ability to restore RASSF1A expression may represent a new class of therapeutic agents. Recently, we designed and synthesized a fluorescent carbazole analogue of mahanine (alkaloid from Murraya koenigii) that restored RASSF1A mRNA expression. Our fluorescent lead compound up-regulated RASSF1A in vitro, potently inhibited human prostate cancer cell proliferation, and fluoresced at a visible wavelength, allowing for the observation of intracellular distribution. The small molecule lead was not acutely toxic up to 550 mg/kg, and dosing at 10 mg/kg reduced human xenograft tumor volume by about 40%.
Introduction: Better biomarkers of cancer risk are needed for smokers to enhance early detection and support the FDA as it considers cigarette performance standards and evaluate health claims for modified tobacco products. This study will identify new biomarkers through metabolomics, a powerful method to identify numerous metabolites and profiles.
Study Design: We utilized a previously conducted epidemiology study of well-characterized smokers. These subjects completed an extensive interview and smoked two cigarettes, one hour apart, in a smoking laboratory. Blood and CO measurements were collected before and after each cigarette. Plasma is available for metabolomic profiling. A pilot study was conducted on 5 light smokers and 5 heavy smokers’ plasma from the study and evaluated whether number of cigarettes per day mediates the influence of global metabolome.
Hypothesis: We hypothesized that the number of cigarettes per day exerts their influence on phenotype through global metabolome.
Methods: Using UPLC-TOFMS in our pilot study, we first analyzed global metabolomic profiles of 5 light smokers and 5 heavy smokers’ plasma and evaluated whether number of cigarettes per day mediate the influence of global metabolomic profiles. The data obtained for multivariate data analyses using Scripps’ XCMS. t-test, SVM (Support Vector Machine analysis), and Random Forest from the Metaboanalyst (www.metaboanalyst) were used for feature selection. The OOB (out-of-bag) error was used to measure the performance of Random Forest classification and the performance for SVMs was estimated using leave-one-out cross validation (LOOCV).
Results: In our results, 1199 peaks in the positive mode and 497 peaks in the negative mode were detected and after feature selection, 816 and 361 peaks were selected in the positive mode and negative mode, separately. Those significant features from all three methods (t-test, SVM and Random Forest) were pooled together for identification using Metlin, MMCD and HMDB databases to obtain the KEGG IDs, and the pooled KEGG IDs were used for Ingenuity Pathways Analysis (Ingenuity@ Systems, www.ingenuity.com). Our preliminary results suggest that smoking behavior is associated with several biological pathways such as cell death, gene expression, cell-cell interaction, and lipid metabolism. The Pathways Analysis also reveals several liver, heart and renal toxicity and altered bile acid biosynthesis, phospholipid degradation due to heavy smoking.
Future Studies: We will further evaluate whether smoking topography and inhalation, as measured by a nicotine boost and CO boost, and whether nicotine metabolism is associated with smokers’ global metabolome by level of smoking.
Citation Information: Cancer Prev Res 2010;3(12 Suppl):B21.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.